Total 5 Posts
A new regenerative tissue therapy allows children born without the gland that produces white blood cells to develop sufficient immune support.
The National Institute of Allergy and Infectious Diseases has awarded more than $36 million to three institutions to conduct research and develop vaccines that can provide broad immunity to coronaviruses such as COVID-19.
Called Paige Prostate, the AI flags potentially cancerous areas in prostate biopsy images for further review by pathologists if they aren’t identified in an initial review.
Started by the MITRE Corporation, Synthea uses publicly available health statistics to create in-depth models that cover artificial patients’ lifespans—but free of privacy, security, intellectual property, or other legal restrictions.
The funding will come from NIH’s National Human Genome Research Institute, which will provide 25 awards to 30 sites across the country through the Impact of Genomic Variation on Function (IGVF) Consortium.